This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: University of California, Alma Mater Studiorum-Universitá Di Bologna, Fondazione Istituto Italiano Di Technologia. Active years: 2017-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Sassari, IT (2017)
- Genoa, IT (2020)
Company Filing History:
2 out of 16,025 
1 out of 94 
1 out of 24 
Years Active: 2017-2020
Title: Marco Migliore: Innovator in Pharmaceutical Research
Introduction
Marco Migliore is a prominent inventor based in Genoa, Italy. He has made significant contributions to the field of pharmaceutical research, particularly in the development of innovative therapeutic agents. With a total of 2 patents, Migliore's work focuses on addressing critical health issues through novel chemical compounds.
Latest Patents
Migliore's latest patents include groundbreaking inventions aimed at modulating biological processes. One of his notable patents is for Piperazinyl methanone NAAA inhibitors. This invention discloses compositions and methods for modulating the activity of N-acylethanolamine acid amidase, which can be utilized for treating pathological states such as pain, inflammatory conditions, or neurodegenerative disorders. Another significant patent is for multitarget FAAH and COX inhibitors. This invention involves multitarget inhibitors of the enzymes Fatty Acid Amide Hydrolase (FAAH) and Cyclooxygenase-1 (COX-1) and/or Cyclooxygenase-2 (COX-2). These inhibitors have a specific carbamate moiety and are designed for therapeutic applications, particularly in the prevention and treatment of cancer.
Career Highlights
Throughout his career, Marco Migliore has worked with esteemed institutions, including the University of California and the Fondazione Istituto Italiano Di Technologia. His research has been pivotal in advancing the understanding of enzyme inhibitors and their therapeutic potential.
Collaborations
Migliore has collaborated with notable researchers in his field, including Daniele Piomelli and Rita Scarpelli. These collaborations have enriched his research and contributed to the development of innovative therapeutic solutions.
Conclusion
Marco Migliore stands out as a key figure in pharmaceutical innovation, with his patents reflecting a commitment to addressing significant health challenges. His work continues to inspire advancements in therapeutic research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile